Growth Metrics

Enanta Pharmaceuticals (ENTA) Shareholder's Equity (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 116.59 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 116.59 Mn
Dec 31, 2025 126.59 Mn
Sep 30, 2025 64.72 Mn
Jun 30, 2025 79.28 Mn
Mar 31, 2025 93.54 Mn
Dec 31, 2024 111.82 Mn
Sep 30, 2024 128.81 Mn
Jun 30, 2024 148.92 Mn
Mar 31, 2024 166.11 Mn
Dec 31, 2023 191.88 Mn
Sep 30, 2023 216.74 Mn
Jun 30, 2023 237.82 Mn
Mar 31, 2023 269.38 Mn
Dec 31, 2022 300.84 Mn
Sep 30, 2022 321.33 Mn
Jun 30, 2022 338.02 Mn
Mar 31, 2022 358.58 Mn
Dec 31, 2021 384.38 Mn
Sep 30, 2021 399.43 Mn
Jun 30, 2021 417.85 Mn
Mar 31, 2021 436.03 Mn
Dec 31, 2020 452.00 Mn
Sep 30, 2020 455.58 Mn
Jun 30, 2020 480.56 Mn
Mar 31, 2020 485.99 Mn
Dec 31, 2019 482.29 Mn
Sep 30, 2019 462.49 Mn
Jun 30, 2019 448.10 Mn
Mar 31, 2019 436.21 Mn
Dec 31, 2018 426.84 Mn
Sep 30, 2018 393.68 Mn
Jun 30, 2018 360.90 Mn
Mar 31, 2018 333.40 Mn
Dec 31, 2017 317.58 Mn
Sep 30, 2017 301.68 Mn
Jun 30, 2017 260.87 Mn
Mar 31, 2017 266.01 Mn
Dec 31, 2016 268.17 Mn
Sep 30, 2016 269.94 Mn
Jun 30, 2016 269.01 Mn
Mar 31, 2016 266.42 Mn
Dec 31, 2015 264.28 Mn
Sep 30, 2015 236.16 Mn
Jun 30, 2015 228.28 Mn
Mar 31, 2015 224.22 Mn
Dec 31, 2014 193.71 Mn
Sep 30, 2014 148.65 Mn
Jun 30, 2014 152.95 Mn
Mar 31, 2014 101.72 Mn
Dec 31, 2013 105.58 Mn
Sep 30, 2013 110.47 Mn
Jun 30, 2013 114.41 Mn
Mar 31, 2013 118.38 Mn
Sep 30, 2012 -115.35 Mn